U.S. FDA approves generic versions of Novartis blockbuster MS treatment
The U.S. Food and Drug Administration on Thursday approved three generic versions of Swiss drugmaker Novartis AG's top-selling multiple sclerosis (MS) medicine Gilenya.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Food and Drug Administration (FDA) | Gilenya | Health | Multiple Sclerosis | Switzerland Health